| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |